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ABSTRACT 
TITLE : A study on the correlation between sputum smear status and  
CD4 count in cases of pulmonary tuberculosis with HIV 
coinfection 
AUTHOR :  SHARMILA B 
BACKGROUND OF THE STUDY : 
Around 2.5 million people are infected with HIV in India. Estimated 40% 
of the Indian population is infected with M.tuberculosis. Estimated 1 million 
persons are co-infected with M.tuberculosis and HIV. Risk of developing TB is 
higher in HIV infected persons. Life time risk of developing TB is 60% in 
persons infected with both HIV and TB. Surveys in India show 1 to 13% 
prevalence of HIV among TB patients. Hence the need of more studies in HIV 
TB coinfection is warranted. 
 WHO states that sputum positivity decreases as CD4 count decreases. But 
this expectation has not been  substantiated in a few studies done in the past. 
 Hence this study was undertaken to find the correlation between sputum 
smear status and CD4 count in cases of pulmonary tuberculosis with HIV 
coinfection in  Tirunelveli medical college hospital ,being a tertiary care referral 
center. 
METHODOLOGY : 
 In our hospital based cross sectional study,50 patients  with HIV infection 
who developed pulmonary tuberculosis were tested for sputum acid fast smear 
status and correlated with CD4 count and radiologic findings. 
RESULTS :  
Sputum smear negative cases were more prevalent  in patients  CD4 
count less than 200 whereas sputum smear positive cases were common with 
CD4 count more than 200 with a statistically significant difference(p=0.0001)  
which endorses the fact by WHO that sputum smear  negativity increases with 
increase in the degree of immunosuppression. 
CONCLUSION :  
Though sputum smear microscopy remains a gold standard method for 
diagnosing pulmonary tuberculosis in immune compromised host with CD4 
count more than 200, there is an urgent need for better diagnostic tools in 
patients with CD4 count below 200. 
KEYWORDS : HIV TB coinfection,WHO,CD4 count. 
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INTRODUCTION 
Tuberculosis   and   HIV   have  been  associated   with   each   other  
ever  since  the  emergence  of  AIDS.    Because  of  the   HIV  pandemic, a 
resurgence in TB epidemic has been observed in India for the last few  
decades. Tuberculosis   remains  the   most   common   opportunistic   
infection  in  HIV  seropositive   individuals   of which     the   most   
common   manifestation is pulmonary tuberculosis ,  irrespective    of  the  
degree  of   immunosuppression . 
           In    India, both     HIV and TB    infection   are  prevalent maximally   
in  the   reproductive    age   group    of   15-49  years ,thus   the   interface   
between  HIV and  TB     is  increased.  The  dual  infection   has   been  
termed   "cursed   duet"
(1)
.  HIV  TB   co-infection  thus   presents  an   
urgent  and   serious   public   health  and   an alarming danger to the 
socioeconomy   of   our   country.  Shortening    the   time   for  pulmonary  
TB (PTB)   diagnosis  and   treatment  initiation   is   an   important   step   in   
decreasing    TB-associated  mortality   and   transmission.  
               One  of  the major challenges  in   diagnosing   PTB (2)  is   alteration 
of   the   presentation   of   PTB  due  to   HIV   infection.  TB and  HIV  
infections   have   an  added  negative   influence  on  the   host   immunity. 
An important marker   in assessing    the   degree of    immunosuppression   
and identifying  HIV   disease   progression is the CD 4 lymphocyte count .  
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The   presentation   of   TB  in  individuals with    HIV co infection  with  
normal   CD4  count   is   similar   to   that   of   HIV-negative patients.   
However,   patients   with   depressed   immunity  (low   CD4  count)  have   
a   pattern   that   is   deviated   from   the   normal,  both   in  clinical features   
and   investigation   findings,   thus   making   diagnosis   difficult. 
               In    countries  with  high   prevalence  of   TB   ,the   most   cost 
effective   method  of  detecting   PTB  among   suspects   is  sputum   smear 
microscopy.  WHO   states   that   sputum   positivity   decreases   as  CD4  
count   decreases.  But   this  finding   has  not  been   proven  in   a  few  
studies  done   in   the   past.  Hence  this  study   has   been   done   in   our   
institution to   better   understand   the   relationship   between   CD4   count   
and the     status  of  sputum  smear. 
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AIM OF  THE  STUDY 
1. To   study   the   correlation   between   sputum   smear   status   and 
      CD4   count   in   cases   of   pulmonary   tuberculosis   with   HIV  
      coinfection. 
2. To   study   the   time   interval   between   the   diagnosis   of   HIV  
infection   and   the   occurrence   of    clinical   tuberculosis. 
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REVIEW  OF  LITERATURE 
EPIDEMIOLOGY: 
In  1993,  TB   was   declared   a   global  emergency.   The WHO‟s   
Director   General      has    recently   declared   AIDS   also as    a Global   
emergency . 
          World   Health  Organization (WHO) states that the global  prevalence 
of    Mycobacterium   tuberculosis 
(3)
   infection  is 33%    whereas in India 
the infection rate   is     40%   .  Among   the   TB  patients of the world, 
14.8%  have   HIV coinfection 
(4)
  whereas   in  India,  5% of  the  TB  
patients   have  HIV  coinfection . 
.       The    global prevalence   of  PLHA
(5)
  is  about  33 million  of  which 
2.5 million  have  coinfection  with  tuberculosis.  In  India,  the  third  
highest HIV   burdened   country  in  the  world,  there  are  around  2.5 
million HIV  infected  people  of  which  1  million   have coinfection  with  
tuberculosis
(6)
.  
In India, it is foreseen that  50 to 60% of    the   HIV-infected   persons  
during their life span  will   develop   TB   disease
(7)
 . 
           India  remains home for a  larger  number  of  tuberculosis (TB)  cases  
in  the  world   accounting   for  23%  of  the  global  incidence  of  TB   
cases i.e. 2  million  of  the  8.8 million  incident  cases  in  2011  were  from  
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India. Indian surveys  show that the prevalence of tuberculosis  in India  is  
14 million,  with an annual incidence of    1.8 million    cases   , of which the 
number of   infectious smear positive cases is  0.82  million.    
Persons   with   Mycobacterium   tuberculosis infection  have   about  
10%   risk   of     reactivation  TB  during     the   rest  of  their   lives.  Thus,  
their  annual  risk of  developing  active  disease  is  less than  0.5%  while  it 
is 10% for individuals  infected with both HIV  and  TB, imposing  a  life 
time risk of   50%  to 60%. 
Approximately  88%  of  HIV  TB  co-infection  cases  occur  in  the  
productive  age  group  of  15 to 49 years.  Therefore,   this  dual  epidemic  
of  TB  and   HIV  poses  a great hurdle   to  the development of our  country.  
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IMPACT OF HIV INFECTION ON THE NATURAL HISTORY OF 
TUBERCULOSIS: 
FROM EXPOSURE TO INFECTION: 
       Exogenous factors mainly determine the  risk  of  acquiring   infection  
with M.tuberculosis.  Mycobacterium  tuberculosis  is  transmitted   by  
droplet   infection from persons with infectious PTB,  less  than  5 microns   
in  size  which  are  aerosolised  by coughing,  sneezing  or  speaking.  Most 
infectious  patients  are  those  with cavitatory disease  and  laryngeal TB  
where  sputum  contains  around  10^5 to 10^7 bacilli.
(8) 
Cavitation is less likely to occur in   persons  with  HIV  TB  co-
infection.  Hence  they  are  be   infectious  when compared to   persons  
without  HIV  coinfection.  
         But evidence  is lacking  whether   HIV patients     acquire  TB  
infection   more when compared to  HIV-seronegative  persons  when  given  
the  same  amount  of  exposure.
(2) 
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FROM INFECTION TO DISEASE: 
In  immunocompetent  persons, following primary infection  with  M. 
tuberculosis,    the  organisms are ingested by the macrophages and the 
mycobacterial antigens are  then  processed   and presented  by  the 
macrophages  to  T lymphocytes. This results in the secretion of 
lymphokines by the  CD4+  T lymphocytes,  which   increase   the 
phagocytic and bactericidal  capacity  of   macrophages  .  In majority of 
individuals , thus  the  infection  is  controlled   and active disease    does  not  
manifest,  though  a  few dormant  bacteria  may  be present   in  the  host
(7)
 . 
Thus   TB can  develop  through  reactivation of  latent  infection,  
progression  of   recently  acquired primary   infection  ,  or   exogenous   
reinfection
(2)
. Endogenous factors, such as   innate   defense mechanisms  
and    function  of  cell-mediated  immunity (CMI)  of the individual 
determine the   risk of developing   active disease
(8)
. 
The risk  of  acquiring  TB  following  new   infection is greatly 
enhanced  by HIV infection.  However,  this  aspect  has not been  studied in 
detail in India.  Primary tuberculosis_tuberculosis disease developing 
immediately following infection  is  common  among  immunocompromised   
persons   because  of defective  macrophage  function  to  contain  the  
infection. 
 
8 
 
   
HIV  is   one of the major   risk   factors  for  the  activation   of  TB 
infection to  clinical  illness.  HIV  infection  is   characterised by a  
progressive decline in the number and  function  of  CD4+ T  lymphocytes,  
together   with  defects  in the function of   macrophages  and  monocytes.    
As the dominant    role  in  anti-mycobacterial  defences is played by CD4+ 
T  lymphocytes  and macrophages, dysfunction  of  these  cells  in   HIV  
infection imposes   a  greater  risk for  primary TB as wells as   reactivation   
TB 
(7)
.  The  lifetime  risk  of  developing  tuberculosis  following   
M.tuberculosis infection   in  immunocompetent  individuals is 10% , with a 
larger proportion  manifesting  within  1-2 year of   infection whereas in  
HIV-coinfected   persons  the risk of developing  active  disease  is  20-30  
times  amplified compared to  non infected persons    , with an annual 
activation    rate of  8-10%  per  year
(2,3)
. 
It  has  been   thought   that     M tuberculosis   infection  in  an  
immunocompetent   person   confers   significant   protection   against  
exogenous  reinfection. But,     regardless of  the HIV status of the individual 
reinfection can occur
(2)
. 
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TB  can  occur  at any   stage  of  HIV  disease. This   risk of  
developing tuberculosis   rises   immediately  following   HIV infection. 
Though  TB  can develop during   early  stages of  HIV  infection,  as the 
CD4   count falls , there  is a  higher   risk  of  developing  TB  especially  
disseminated  disease. 
The rate  of  recurrent  TB   disease is increased by HIV infection ,  
which   could be   because of   endogenous    reactivation  (true relapse)   or   
exogenous    re-infection
(7)
.  
Thus  HIV infection causes an increase  in the incidence  of   active 
tuberculosis  cases    exposing the general community to a higher     risk  of  
TB . 
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IMPACT OF TUBERCULOSIS ON THE NATURAL 
HISTORY OF HIV INFECTION:   
Coinfection with M.tuberculosis  accelerates   the  rate of     
progression  of HIV disease  resulting in higher mortality, especially   in   
individuals with  who are not treated  for  HIV  . This is the result of   
enhanced  immune activation  and an   increase in the  expression  of    
CXCR4 and  CCR5    coreceptors on  CD4  cells
(2)
. 
The effect of  TB  on   the levels of HIV  RNA   is  doubtful. However 
, studies have  showed  increased   levels of HIV RNA  in the presence of 
HIV TB-coinfection  ,  which  results from  multiplication  of  latent  virus 
residing    in  macrophages  and  dysregulated  cytokines
(2)
. 
Thus  TB  shortens  the  lifespan  of HIV  patients  . This   higher  
mortality  is due  to  rapid  progression of HIV to  AIDS  rather  than  TB 
itself. 
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CLINICAL PRESENTATION OF TUBERCULOSIS IN HIV 
INFECTION: 
During  the  course  of  HIV  infection, TB  can   occur at  any time  . 
The most  common  presentation  of  TB in HIV TB coinfection is .  
pulmonary  TB  .   
There is   possibility  of  TB  being  overlooked in  HIV-infected   
patients  because   symptoms  of  fever,  malaise and weight loss  can   be  
due   to HIV infection  itself  .Patients usually have  symptoms   over several   
weeks to months.  However, a sudden  onset of  cough with fever in these 
individuals suggests a  nonmycobacterial  pulmonary  process. 
The clinical presentation of TB is influenced by the severity of 
immuno-suppression in the patient. In  early  stages   of   HIV  infection, TB  
usually manifests as  post -primary pulmonary TB with upper lobe 
involvement, cavitatory  lesions and  positive sputum smear status.  During   
late   stages of HIV infection,    PTB  often  presents  as     primary 
tuberculosis   with  , lower lobe involvement , infiltrative  lesions, intra  
thoracic  lymphadenopathy  and    negative sputum smear status. 
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 The incidence of    smear negative  pulmonary  TB  has  increased  because 
of   the TB- HIV co-epidemic. 
HIV  infection  increases  the  prevalence  of   extrapulmonary  TB  
and   disseminated   TB  .  As the  CD4 cell count decreases, there is    an 
increase in the   occurence of extrapulmonary TB  and atypical chest 
radiographic findings, due to defective  immune response to contain 
infection.Manifestations of   extrapulmonary  TB depends on    the  organ 
affected , such  as    abdominal pain, ,  meningismus, headache, back pain,  
abscess   formation, , pyuria , lymphadenopathy etc
(2) 
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DIAGNOSIS: 
Diagnosing  TB in the presence of  HIV-infection is often  
challenging.  
          There is a  higher rate  of  sputum  smear   negative  TB in HIV 
affected individuals to  as high as 66%.  Such   smear-negative PTB cases  
may be   culture-positive  and is seen commonly  with    advanced  
immunosuppression. 
           Generally, the   sputum smear positivity rate  correlates with  the 
pattern   of radiographic changes. For example, individuals  with cavitatory 
disease  are more likely to be sputum smear   positive ,   whereas in  patients  
with  minimal  changes  on  chest  radiograph   a negative smear result  is 
.more common . However, in the presence of  HIV-infection, patients with 
little radiographic evidence may have  positive  sputum  smear  results.  
           Other difficulties  in establishing the  diagnosis  of  TB   in the 
presence  HIV infection are  an   increased occurrence    of  extrapulmonary 
TB  and difficulty in  differentiating   TB  from  HIV associated  neoplastic  
conditions  and other HIV associated  infections
(2)
. 
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SYMPTOM  SCREENING: 
       In a TB patient, the  conditions  that  should   arouse  the  suspicion  of    
HIV   infection are as follows
(9)
: 
 Oral/ Oesphageal candidiasis 
 Oral hairy leukoplakia 
 Fever >1 month 
 Chronic diarrhea >1 month 
 Weight loss of  > 10% in the past 6 months  
 
 Recurrent pneumonia 
 
 Herpes Zoster 
 
 Typhoid 
 Generalized dermatitis 
 Kaposi's sarcoma 
 Present or past genital ulceration 
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           Clinical suspicion of  HIV infection in TB patients can be confirmed  
by referring these  patients to Integrated Counselling and Testing  
Centres(ICTC). .  
           In HIV positive patients , symptoms  that should arouse the  suspicion   
of   TB  are as follows : 
 Cough  of 3 weeks  duration or more 
 Fever of more than 2-3 weeks 
 
 Haemoptysis 
 Unexplained dyspnoea or chest pain 
 
 Weight loss 
 Lymph node enlargement  
 
 Headache, vomiting, alterated sensorium or convulsions 
 Fatigue, listlessness 
 
 
        HIV positive patients with clinical suspicion of TB  should be referred 
to the Revised National Tuberculosis Control  programme(RNTCP) health 
centres for  establishing  the diagnosis of TB. 
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INVESTIGATIONS: 
AFB   MICROSCOPY: 
               Microscopy is the  easiest ,oldest ,fastest  and least expensive 
procedure to detect the prescence of acid fast bacilli. 
              Minimum of  10^5 bacilli per milliliter of specimen must be present 
to detect    tubercle bacilli  in stained smears.  In contrast, 10 to 100 bacilli 
are  sufficient  to give  a  positive  culture.  Thus  acid  fast smear  is less 
sensitive than culture  and hence  cannot  replace culture
(10)
. 
           Smear  examination  is  a  rapid  procedure  making   results ready   
within  24 hours of  specimen  collection .  
           However,   only the presumptive  diagnosis of TB disease  can be 
made with smear microscopy  because  there are  acid-fast bacilli  other  than  
M. tuberculosis.   
          Patients with an initial  negative AFB  smear may have  a subsequent 
positive  culture. Therefore  TB disease cannot  be excluded by a negative 
smear. 
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The 3   commonly  used procedures for  acid-fast  staining
(11)
 include:  
1.  Ziehl-Neelsen  method or hot staining method using carbol fuschin dye 
under light microscope.                                                                             
2.  Kinyoun  method or cold staining method using carbol fuschin  under 
light microscope. 
3. Truant method_ using the fluorescent dyes like  auramine-O                                                                    
and   auramine- rhodamine fluorochrome  under fluorescent  microscope. 
Specimens  for  pulmonary  tuberculosis
(11)
: 
 Spontaneous  sputum  produced  by  coughing 
 Sputum   induced by 3 to 5% hypertonic  saline 
 Bronchoscopy  aspirate 
 Gastric  aspirate 
Specimens  for extrapulmonary  tuberculosis: 
 Tissue  biopsies 
 Body fluids ( pericardial,pleural, synovial,  ascitic fluid, CSF, bone 
marrow, blood, pus). 
 Urine.  
 
It  has been  recommended  that in persons with suspected pulmonary 
TB  ,minimum of  2 sputum samples  should be  examined  for  AFB smear . 
There   is limited increment in the  yield by using a  third sputum for AFB 
smear, as  low as 2% 
(2,12,13)
. 
18 
 
Ziehl  Neelsen  staining: 
 Step 1:slides are fixed by using heat flames. 
 Step 2:The entire slide is flooded  with carbol fuschin 
 Step 3:The slides are heated  slowly until they  are  steaming and the   
steaming is maintained   for  5  minutes by  low or intermittent heat 
 Step 4: The slide is rinsed  with  water 
 Step 5:The  slide is flooded   using  3% acid-alcohol  or 20% sulphuric 
acid  and then allowed  to  decolorise for 5 minutes by  continued    
flooding of   the slides with   till  the  slides are free  of any  stain 
visible to naked eyes 
 Step 6:The slides  are rinsed  thoroughly  with water and   any excess 
from the slides is drained. 
 Step 7:The slide is flooded  with counterstain ,methylene blue and  the 
counterstain is kept  on the slide for 1 minute 
 Step 8:The slide  is rinsed thoroughly with water 
                The slide is examined under oil immersion. 
                  Before a smear is  being reported as negative,a minimum of 100 
fields has to be examined. 
19 
 
                 An easy  method  of examination is to have  3  passes along the 
long axis of the slide or  9  passes along the short axis of the slide so as to 
view the entire slide.
(10) 
                 M. tuberculosis is a thin , rod-shaped, non spore-forming, aerobic  
bacterium . Acid fastness is due  to the  high  content of mycolic  acids, 
cross-linked     long-chain   fatty acids, and  other  lipids present in the cell 
wall of the organism.  Other  acid  fast microorganisms include  Nocardia , 
Rhodococcus,  the protozoa Isospora and Cryptosporidium and Legionella  
micdadei.  The primary stain (fuchsin)  binds to the  mycolic  acid of cell-
wall  . Acid alcohol  or  strong  acid used as a decoloriser  fails    to  release 
fuschin  from the cell wall  and hence  the red colour of carbol  fuchsin is 
retained by mycobacteria – thus  acid-fastness.The counterstain, methylene 
blue gives a contrasting background. 
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Figure 1 : Acid fast bacilli seen under light microscope 
                         
GRADING OF AFB BACILLI: 
NUMBER OF AFB SEEN REPORT 
0 Negative 
1 to 9/100 fields Doubtful/ Scanty 
10 to 99/100 fields 1+ 
1 to 10/field 2+ 
>10/field 3+ 
      
In  the presence of HIV infection,   sputum microscopy has a 
sensitivity that  varies between   43%  to 51 %,  and    the sensitivity is 
further  decreased in  many  resource-limited  settings
(14)
  with  higher co-
infection rates.  
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Techniques that can increase the  yield  of smear microscopy  are 
alternative specimen processing techniques
(15)
 like bleach sedimentation, 
concentration 
(16)
 and fluorescence microscopy
(17)
 . 
In  resource-limited  settings, the use of fluorescent microscopes is 
limited by their higher cost   . This problem has been dealt by  making use of  
light-emitting diode bulbs
(18,19)
 that  permit  the usage of    fluorescence 
microscopes at a lesser price. Another disadvantage of smear microscopy is  
that drug susceptibility couldnot  be tested. 
 
Figure 2  :TB bacilli seen under fluorescent microscope 
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MYCOBACTERIAL  CULTURE: 
Mycobacterium tuberculosis is detected by culture with a better    
sensitivity  than  smear  microscopy  and therefore helps in  the diagnosis of 
TB in HIV-infected individuals. Strain characterization  and  drug  
susceptibility  testing can also be done with the help of culture. 
The   culture medium that are traditionally used include
(20)
: 
 The  L-J medium(Lowenstein-Jenson medium) which is an egg-
enriched  
           medium  with  glycerol  and asparagine    
 Middlebrook medium which is  an agar based medium  supplemented 
with  bovine  albumin. 
Though  traditional culture   methods are   sensitive, they are   slow 
and it  may take   6-8 weeks   of  incubation for the growth to become 
visible. This  causes a  delay  in the  initiation of  therapy,  which 
inturn has   deleterious   effects  on the   outcome of  HIV TB   
 co-infected patients.  
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Growth  characteristics  of  M.tuberculosis  in  solid  media
(20)
 are 
• In  primary  culture,growth of tubercle bacilli  is  not visible within a   
week and     usually  takes 2 to 4  weeks to give visible growth. 
• Colonies appear like   breadcrumbs  or cauliflower because they are rough 
and buff coloured. 
• Growth   is  not  emulsifiable  and appears   as granular  suspensions.    
• Microscopically  they  appear like  serpentine cords  or has  linear clumps  
in liquid medium. 
Figure 3 : TB colonies grown in culture 
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           Newer methods of    culture include   automated liquid culture 
systems 
(21)
 which can rapidly  detect the  mycobacterial growth within 1-
2weeks  by  identifying  bacterial  oxygen consumption or carbon dioxide 
production  with  the help of  
 colorimetric sensors(MB/ BacT system) 
 redox reagents such as Alamar blue(22) 
 
 fluorescent sensors [BACTEC Mycobacteria Growth Indicator  
 Tube (MGIT) 960]
(23) 
 radiometric sensors (BACTEC 460TB)  
 pressure sensors(ESP culture system II) 
 
Microscopic  observation drug susceptibility(MODS) assay
(24)
,  
 a cheaper, less commercial method    is utilised  for the early identification  
of growth of   microcolonies and  drug resistance. It has got  better 
sensitivity, rapid growth  and less costly compared to   regular L-J medium. 
Bacteriophage  based  assays
(25)
  are novel methods  employed  for 
TB  diagnostics . The FAST Plaque TB assay is one such assay that  can 
identify   mycobacteria  in  50-65%  of  smear  negative  samples with  98%  
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specificity. The diagnostic  accuracy  of these assays is increased  by  
performing them  on culture isolates.  However,  in HIV-TB co-infection  
this method has a lower sensitivity  with a higher risk of contamination. 
Newer  rapid  diagnostic technologies  that are under pipeline include  
colorimetric culture system
(26)
 using TK medium culture system and 
recombinant mycobacteriophages  . These  automated systems have  
increased sensitivity  and .require shorter  time period   for positive culture  
(9-10 days). Rapid culture results results in faster  treatment implementation. 
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CHEST X RAY: 
The cornerstone  for the    diagnosis of   pulmonary  TB is chest  
radiograph. The typical findings in reactivation TB are upper-lobe  infiltrates  
and cavities, whereas lower-lobe disease and intrathoracic   
lymphadenopathy  are evident  in primary TB. 
          HIV-infected individuals  having  higher CD4 counts ie, >200 cells/µL  
have    radiographic  changes    mimicking   reactivation TB  as evident by  
upper-lobe infiltrates and  cavities. 
          HIV-infected individuals having a higher degree of 
immunosuppression ie, CD4 count <200 cells/µL  have  radiographic  
changes mimicking   primary TB as evident by  lower-lobe  infiltrates, 
intrathoracic lymphadenopathy  and military pattern . 
           Normal    chest  radiographs  can occur in   21% of   culture-positive   
cases   with  CD4  count  <50 cells/µL. This exemplifies the necessity  of  a 
high degree   of   suspicion   while  evaluating  HIV  patients  with  
symptoms  suggestive of TB. 
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Figure 4 : Chest X ray showing cavity in right lower zone in HIV TB 
coinfection 
 
Figure  5 : Diffuse nodular infiltrates seen in CXR of HIV TB coinfected 
patient 
 
28 
 
 
CT CHEST: 
              CT  chest   has  a  role    in  interpreting  doubtful findings on plain  
chest radiography. It also   helps in the  diagnosis of  some forms of 
extrapulmonary TB  like  Pott's disease. 
               CT chest helps to  differentiate old fibrotic lesions from new active 
lesions. Early active tuberculosis is characterised by  lesions in and around 
the small airways  and may be  taken as a reliable criterion for disease 
activity. 
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MOLECULAR TECHNIQUES: 
NUCLEIC ACID AMPLIFICATION TESTING (NAAT): 
        Nucleic  acid  amplification  testing (NAAT)  has  increased  
specificity  but  variable  sensitivity,  particularly   in  paucibacillary  
disease. Well standardized and  reproducible  commercial kits  are now 
available. However,  there  are limitations for their use in resource-limited 
settings such as lack of data    regarding   their   reliability ,accuracy,  higher  
cost, requirement  for   strict quality control and requirement of  proper  
laboratory  infrastructure. 
         Various modifications  of  NAAT
(27)
   include 
 Line  probe  assays (LPA)(28) 
 Fluorescence  in-situ  hybridization (FISH)  
 Loop-mediated  isothermal  amplification (LAMP) 
        Line probe assays  have  got  higher  sensitivity of  >95%  and  
specificity of 100%  especially  when culture isolates were used. Line  probe 
assays have been   endorsed   by  WHO   for  the detection  of   M. 
Tuberculosis  and detection of    rifampicin and   isoniazid resistance on 
sputum  smear-positive   samples and  culture growth isolates. 
 
 
30 
 
                 In   India,  the Intermediate Reference Laboratories governed   by  
the Revised National TB Control Programme (RNTCP) use  line probe 
assays    together with culture. 
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GENEXPERT-RIF: 
GeneXpert-Rif has been recently endorsed by WHO  for  the rapid 
detection  of  TB bacilli  and detection of  rifampicin resistance in TB 
suspects of PLHA  . GeneXpert is an automated, TB-specific ,cartridge-
based nucleic acid amplification assay, that has got a  completely automated 
and  integrated  sample preparation, amplification and detection using real-
time PCR, thereby  making  results  available within 100 minutes.  
A  single direct  Xpert  MTB/RIF  test  can detect  92.2%  of  culture-
positive  patients    whereas a  a single direct smear  can detect  59.5% of 
culture positive cases.In addition, a  single Xpert MTB/RIF test can also 
detect 72.5%  of  smear-negative/culture  positive  cases  whose sensitivity 
can be increased to 90.2 % by using  three  samples. Xpert  The   specificity 
of this method  is  99%. Advantage of this newer technique is that   in the 
presence of HIV co-infection, the  sensitivity of direct  microscopy is 
significantly reduced  to 47% in this setting , but did not significantly affect  
the sensitivity  of Xpert MTB/RIF
(29-33)
.  
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In the   detecting  rifampicin resistance , it has got 99.1% sensitivity and  
100%  specificity.  
Average  time taken  for  diagnosis of tuberculosis  using   Xpert 
MTB/RIF is  <1 day  whereas by  microscopy it is 1 day, by  liquid  culture it 
takes 17 days   and  >30  days  in   solid culture
(32,33)
.  Therefore  this  
technique  appears  to have the  ability   to  complement   the  current  
reference standards  for  TB diagnostics and enhance  its  speed and 
sensitivity.  
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SEROLOGICAL  DIAGNOSIS OF TUBERCULOSIS: 
DETECTION   OF ANTIBODIES: 
The  commercial serological tests
(34,35)
 available in the market  have   
not shown adequate  specificity and sensitivity to be recommended for 
diagnostic use.  Recently a  negative  recommendation has been made by 
WHO   against  the usage of serological tests for diagnosis of  
tuberculosis
(36)
. This is based on information which   highlights the fact  that 
these tests could  not either replace   microscopy  or be used as an add-on 
test to rule out TB.  RNTCP has endorsed this fact and is applicable  in India, 
where estimates show that   millions  of such   investigatons are done  in the 
private sector resulting in  wastage  of resources
(37)
. 
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DETECTION    OF   ANTIGEN: 
ELISA–based  commercial  assays can detect  mycobacterial  antigens  like 
 M. Tuberculosis  MPB-64 (TAUNS)  antigen  in  peripheral  blood 
 lipoarabinomannan (LAM) in  the  urine 
 Early  secreted   antigenic  target  6 in  the  cerebrospinal  fluid(38) 
           Urinary   LAM  assays  happen to  yield   better results  in HIV TB co 
infected  patients when compared to non HIV   TB patients  especially  when  
CD4 counts  is less than 50 cells/µL, which  could be due  to the increased 
occurrence of disseminated TB in them
(39,40)
. However,  urinary LAM  assays  
have a  low overall sensitivity (40-60%) in culture-positive  TB  patients  
with  HIV  coinfection  but is  increased  to 67-85%  when there is a decline 
in  CD4 count to  <50 cells/µL. Specificity  in HIV TB coinfection is 99-
100%. The combined use  of   sputum  smear microscopy and  urine 
lipoarabinomannan assay  needs further studies   in  high HIV burden 
settings. 
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DIAGNOSIS OF LATENT INFECTION: 
TUBERCULIN SKIN TESTING: 
         This test  is  used widely  to screen  latent M. tuberculosis infection(41) . 
It consists of an intradermal injection  using   tuberculin-PPD.  This test has 
got  low sensitivity and specificity and it does not  differentiate between 
latent infection and active disease thus  limiting its   role in the diagnosis of 
active TB  False-negative reactions occur  in immunocompromised patients 
and in individuals  with overwhelming TB. False-positive reactions  are 
caused by atypical   mycobacterial infections   and  by BCG vaccination. 
Despite having  TB infection or  disease,HIV   infected  patients can  have a 
negative tuberculin  test due to anergy. 
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INTERFERON   GAMMA   RELEASE   ASSAY (IGRA): 
           This  test  used to diagnose  latent TB infection   is  particularly  
useful in seriously  ill patients and those with severe  malnutrition. 
            2 types of IGRA are available
(11)
:  
 QuantiFERON- TB Gold   
 T SPOT-TB test. 
Both are  enzyme- linked immunospot assays that  quantify the 
number of  mononuclear cells in peripheral blood  producing IFN- γ in  
response to tuberculosis specific antigen stimulation (ESAT-6 and 
CFP10).The  sensitivity of these tests are  similar  to that  of the tuberculin 
skin test, but  with are   costlier. 
Disadvantage of  IFN-γ  assays  is that they do not distinguish  
between  active and latent  tuberculosis or  IRIS and treatment  failure.  
IGRAs are suitable for serial testing because they can be repeated 
without boosting. They are   not affected by previous BCG vaccination. They 
need  fewer  patient visits. 
IGRAs  are more  specific  than  TST   because of lesser  cross-
reactivity to BCG vaccination and atypical  mycobacteria. However, WHO 
has given negative  recommendation  against   IGRAs for their use in  
diagnosis of latent or  active  TB, in resource limited settings
(42,43)
. 
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TREATMENT   OF   HIV TB   COINFECTION : 
There is no cure  for HIV/AIDS till date. There are treatment options  
only  for  the opportunistic   infections   arising   from  the  disease. Anti 
retroviral drugs act by  slowing   the action of the virus  thereby prolonging  
the life of patients.  TB treatment in HIV coinfected individuals is similar to 
those of     TB  patients without HIV coinfection
(9)
. 
ANTI-TB THERAPY: 
Standard anti_TB   therapy has  4  drugs in the intensive phase  
namely (H)isoniazid, (R) rifampicin , (Z)  pyrazinamide and (E)ethambutol  
for 2 months  and 2 drugs  in the continuation phase namely H and  R for  4  
months
(44)
.  RNTCP recommends  Category I (2HRZE3/4HR3) ,  an  
intermittent thrice weekly regimen  for  new  TB cases. For relapse cases - 
Category II(2HRZES3/1HRZE3/5HRE3) is given where  streptomycin (Sm)  
is added in the intensive phase and  duration of treatment is  prolonged to 8 
months. The   key  drug  in the treatment of   TB in HIV infected individuals 
is rifampicin because it has the   ability to kill  both intracellular bacilli and 
intermittent and slow growers of  TB  bacilli.  
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 Increasing the treatment duration  to 9 months did not  improve  the  
outcome  of  the    treatment, however   TB  recurrences  were  significantly  
reduced  during the  follow  up period
(45)
.  Studies are  showing   that   
intermittent regimens are associated with  an increased risk of failure and a  
higher  probability of   rifampicin  resistance,  particulary   in  ART naïve 
individuals . This  has  led  WHO  to  suggest   daily  TB regimens (at least  
in  intensive phase)  rather than  intermittent regimens for  HIV-TB patients 
.Concurrent ART during TB treatment results in  better  treatment  outcomes, 
lower  case  fatality  rates,lesser  failure  rates  and recurrence rates. As there 
is no strong  evidence  to support  changeover to daily regimen  and to show 
the   superiority   of  intermittent regimens, this recommendation has not 
been followed   in India. 
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 ANTI-RETROVIRAL THERAPY:  
 
In resource  limited  settings  , WHO    recommends   the use of two 
nucleoside reverse  transcriptase  inhibitors (NRTIs)  in combination with  
one non-nucleoside reverse transcriptase inhibitor (NNRTI) as  first line 
therapy for the  treatment  of  HIV-infected  TB patients
(46)
. In India, a triple 
regimen  consisting of zidovudine or stavudine ,  lamivudine  and  efavirenz 
is recommended by NACO
(47)
. 
          The  cytochrome  CYP-450 enzyme  system  which is located  in the 
liver and intestinal wall is induced by rifamycins, thus  accelerating  the 
metabolism of  NNRTIs and  PIs . This inducing  effect is weaker with 
rifabutin when compared to  rifampin.  When  rifampicin and certain  
antiretroviral  drugs are given in combination, it results in  reduced  trough 
levels of the latter , resulting in  therapeutic  failure
(48)
.  There is a reduction 
in Nevirapine  levels  by  40–55 %, delavaridine by 96% ,efavirenz by 18-25 
%, and most PIs by 80-90 %.  
In India, Efavirenz  600 mg once daily  is  the    NNRTI  used  in HIV-
TB    co-infected individuals  in India. A  triple NRTI regimen or a regimen 
consisting  of  two NRTIs  and  nevirapine is used if patients cannot  
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tolerate or have contraindications to efavirenz (e.g., pregnancy, psychiatric 
disturbances).   An  alternative  strategy is to alter  the  anti-TB regimen  
with   rifampicin replaced by rifabutin – the  recommended dose of rifabutin  
is 300 mg OD twice/thrice-weekly  together with nevirapine based ART. 
Contraindications for rifabutin include  leucopenia and thrombocytopenia 
while  uveitis  occurs with higher doses . 
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TIMING  OF ART & CONCOMITANT ADMINISTRATION 
WITH ATT:  
Early initiation of  ART has the advantages of   decline  in early 
mortality, decline  in  relapses ,better  cure  rates,   decrease in  
malabsorption thus    preventing  ATT drug  resistance    and  a decrease  in   
the occurrence  of other  opportunistic infections besides  TB
(49)
. 
It has got  disadvantages like a   higher risk of developing IRIS, 
cumulative drug  toxicity, drug interactions of ART with  rifampicin  thus   
restricting the choice of combinations . These   in turn can  have an adverse 
impact on the  long term compliance of these patients. 
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TREATMENT  STRATEGY  FOR  HIV TB  COINFECTION 
 
 
 
MANIFESTATION ATT ART 
Extrapulmonary TB 
(regardless of CD4 count) 
Start immediately  ART to be started as soon as 
 ATT  is  tolerated (between 
 2 weeks to 2  months) 
Pulmonary TB  
CD4 <200 cells/mm3 
Start immediately ART to be started as soon as 
 ATT is tolerated (between 
 2 weeks to 2 months) 
Pulmonary TB 
CD4 = 200–350 cells/mm3 
Start immediately  ART to be started after 
 completing intensive  phase of 
ATT (start earlier if severely 
compromised) 
Pulmonary TB 
CD4 >350 cells/mm3 
Start immediately Monitor CD4 count. 
 ART to be considered  when 
 CD4 cell count falls  below 350 
cells/mm3 
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IMMUNE RECONSTITUTION INFLAMMATORY 
SYNDROME(IRIS): 
           IRIS is defined as a  transient deterioration  of   signs and symptoms 
of tuberculosis or radiological  worsening  after  the initiation  of  ART,  
inspite  of  HIV load reduction (>1 log10 copies/μl) and immunological 
recovery
(50)
. Before a diagnosis of IRIS is being  made, drug  resistance  and  
other  opportunistic  infections  must  be ruled out. A  peculiar  feature of  
IRIS  in tuberculosis is hypercalcemia. 
                IRIS  has   two  types  of  presentation: 
 unmasking   IRIS  and  
 paradoxical IRIS 
       The incidence of IRIS in tuberculosis  varies  from 8 to 43%. 
IRIS can manifest as  fever,  worsening  respiratory  symptoms and 
signs,  worsening  CNS   lesions  such as tuberculoma and meningitis , psoas 
abscess, cold abscess and  lymph node enlargement
(2)
 . 
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Figure 6 : Types of IRIS 
A, B and C_ unmasking IRIS; D, E, F _ paradoxical IRIS. 
(A) Asymptomatic patient when started on ART; (B) developed miliary TB 
after ART –unmaskingreaction; (C) After ATT showing resolution; (D) 
Patient with miliary TB at baseline; (E) After 1month of ATT treatment; (F) 
After ART showing flare up of lesion (paradoxical reaction) 
(A)                                          (B)                                      (C) 
 
                  (D)                                     (E)                                        (F) 
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Genetic predisposition(HLA B-44),high bacillary  antigen load at  the 
start of treatment,   higher viral load   at   initiation  of   treatment,    lower 
CD4 cell count, very rapid  decline in  viral load , starting  ART closer  to 
the  starting  of   ATT are probable risk factors for the development of IRIS. 
Pathophysiology of IRIS is not  yet  fully  understood, it  is  thought to 
be due to increased   production  of  cytokines like  IFN-γ or  a  deficiency   
of  inhibitory  immune  responses
(51)
. 
IRIS is usually  managed  with  anti-inflammatory drugs and steroids. 
Death is a rarer  outcome in IRIS  and  is commonly seen with CNS IRIS. 
ART termination is not needed usually. 
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MATERIALS AND METHODS 
 
INCLUSION CRITERIA:  
           Adult   patients (>12 years)  satisfying  WHO  criteria for the 
diagnosis of  pulmonary tuberculosis , with  HIV coinfection
(21)
. 
Smear-positive   pulmonary  tuberculosis 
• Acid-fast  bacilli (AFB) positive in sputum  smear  and 
 • HIV  infection confirmed in laboratory 
Smear-negative pulmonary tuberculosis 
•AFB  negative  in  at  least  two  sputum  specimens    and 
• Radiological  picture  suggestive  of   active  tuberculosis  and 
 • HIV  infection confirmed in laboratory 
EXCLUSION CRITERIA: 
 Diabetes mellitus 
 Chronic renal failure 
 Long term steroid/other immunosuppressants intake 
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METHODOLOGY 
             This  hospital  based   non   randomised   cross   sectional  
observational   study  was  conducted  in Tirunelveli  Medical  College  
Hospital, a  tertiary care  referral   centre  located  in  the  southern  part  of  
Tamil  Nadu.  After giving written informed consent , 50 eligible patients  
admitted  with  pulmonary  tuberculosis  and  HIV coinfection in the medical 
wards, ART centre and Thoracic medicine wards of our hospital from 
August 2012 to August  2013  participated  in  the study. The research 
protocol was approved by the  Institutional Ethical Committee of Tirunelveli 
Medical College. 
             Patients  were  enquired  about   symptoms  such  as  cough , fever , 
hemoptysis, weight  loss , loss  of  appetite, etc.   and    underwent  a  
thorough  clinical  examination. 
             Patients   were   instructed   to produce two  expectorated   
sputumsamples,  of   which   atleast  one  is an  early morning sample. In  the 
laboratory   of   RNTCP   Designated   Microscopy  Centre (DMC) of our 
hospital, sputum  samples  were  tested  for  AFB  by  Ziehl  Neelson  
method. 
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 100 microscopic fields were visualised in each smear. Smears were  
categorised  as  positive  or  negative.  One specimen positive out of the two  
is  enough  to declare a patient as  smear  positive  TB.  
Sputum  density  was  further  graded  as   
3+ (>10 AFB/oil field) (20 fields to be examined), 
2+ (1 to 10 AFB/oil field) (50 fields to be examined), 
1+ (10 to 99 AFB/100 oil fields), 
Scanty (1 to 9 AFB/100 oil fields). 
Chest  X  ray  posteroanterior  view  was  taken  for  all  the  patients. 
In  all  the  smear negative cases, CT chest  was  taken  and  expert opinion 
given  by  radiologists of our hospital.  
In addition to the baseline investigations like Complete Blood Count, 
blood   sugar,  urea, creatinine, LFT  that  were  done in  biochemistry  lab,  
CD4  count  was  done  in  ART  plus  centre  of  our   hospital by   flow  
cytometry. 
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STATISTICAL ANALYSIS 
The  information    obtained from   study participants    were tabulated  
in  an  Excel   Master  Chart.  Using  Epidemiological Information 
Package (EPI 2010)   organised by  Centre  for  Disease  Control,  Atlanta  
further  the data were analysed using a computer. 
By utilising   this   software    means, standard deviations, frequencies,  
percentages, range  and  'p' values  were  obtained. The significance of 
difference between quantitative   variables was determined by using  Kruskul 
Wallis     chi-square  test   and   for qualitative variables  Yate‟s   chi   square 
test   was used. A  'p'  value of   less  than  0.05  was considered to indicate   
significant  relationship. 
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OBSERVATIONS AND ANALYSIS 
50 patients  with pulmonary tuberculosis and HIV coinfection who 
fulfilled the inclusion criteria participated in the study. 
The  observations  made   were  as  follows: 
A. PROFILE  OF  CASES  STUDIED: 
AGE: 
 
 
 
 
 
 
 
 
 
    
 
12% 
52% 
30% 
4% 
2% 
21 30 yrs 31  - 40 yrs 41 - 50 yrs
51 - 60 yrs > 60 yrs
Chart 1: AGE DISTRIBUTION 
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        Among  the  study  group,  the  minimum  age was 27   years and  
maximum age was  65  years. 
The mean age was  39.3 years. 
Table  A1 : Age distribution 
 
Age group 
Cases 
No % 
13-20 years - - 
21-30 years 6 12 
31-40 years 26 52 
41-50 years 15 30 
51-60 years 2 4 
> 60 years 1 2 
Total 50 100 
Range 27 - 65 years 
Mean 39.3 years 
SD 8.0 years 
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SEX:                  
      Of  the  50 patients,  39  were  male  and 11 were female. 
Table  A2 : Sex distribution 
 
Sex 
Cases 
No % 
Male 39 78 
Female 11 22 
Total 50 100 
                                           
 
 
 
 
 
 
 
 
 
78% 
22% 
MALE FEMALE
Chart 2:  SEX  DISTRIBUTION 
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TIME INTERVAL: 
                Among the 50 patients, 26  patients   had  pulmonary   tuberculosis 
during the initial    diagnosis   of  HIV  infection 
Table  A3 : Time interval 
 
Time interval 
Cases 
No % 
New 26 52 
1 year 6 12 
2 years 6 12 
3 years 1 2 
4 years 1 2 
5 years 3 6 
>5 years 7 14 
Total 50 100 
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                Among  the  50  patients , 26   patients   had  pulmonary   
tuberculosis during the initial    diagnosis   of  HIV  infection. 
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Chart 3: TIME     INTERVAL 
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SPUTUM   STATUS: 
            Out  of the 50 patients with HIV_TB coinfection , 25 were sputum 
smear positive  and  25 were  sputum  smear  negative. 
Table  A4 : Sputum status 
 
Sputum status 
Cases 
No % 
Positive 25 50 
Negative 25 50 
Total 50 100 
 
 
 
 
 
 
 
 
 
50% 
50% 
POSITIVE NEGATIVE
         Chart 4:           SPUTUM STATUS 
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SPUTUM DENSITY: 
          Among  the  50 sputum  positive  cases, seven cases  had  scanty 
positivity, five cases   had  1+, six cases   had  2+  and  six cases  had  3+  
status. 
 
 
 
 
 
 
 
 
 
 
 
 
50% 
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NEGATIVE SCANTY 1 + 2 + 3 +
Chart 5: SPUTUM   DENSITY 
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Table  A5 : Sputum density 
 
Sputum density 
Cases 
No % 
Negative 25 50 
Scanty 7 14 
1+ 5 10 
2+ 6 12 
3+ 7 14 
Total 50 100 
                         
          Among  the  50 sputum  positive  cases, seven cases  had  scanty 
positivity, five cases   had  1+, six cases   had  2+  and  six cases  had  3+  
status. 
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CD 4  COUNT: 
                     Of  the  total  50  cases, 32  had  CD4 count  less  than 200 cells 
and 18  had  CD4 count  more  than 200. Mean CD4 count was 172.9 
Table  A6 : CD4 count 
 
CD4 count 
Cases 
No % 
0-50 9 18 
51-100 7 14 
101-150 8 16 
151-200 8 16 
201-250 4 8 
251-300 5 10 
301-350 7 14 
>350 2 4 
Total 50 100 
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Upto 200 32 64 
>200 18 36 
Range 18-411 
Mean 172.9 
SD 109.2 
 
 
 
 
 
 
 
 
 
 
 
 
64% 
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Chart 6:  CD 4   COUNT 
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 RADIOLOGICAL  FINDINGS:            
          Infiltration was the most common radiologic finding followed by 
consolidation  and  cavity . 
Table  A7 : Radiological findings 
 
Radiological findings 
Cases 
No % 
Upper zone infiltration 14 28 
Midzone infiltration 1 2 
Mid & lower zone infiltration 8 16 
Lower zone infiltration 5 10 
Diffuse infiltration 3 6 
Upper zone cavity 4 8 
Mid zone cavity 1 2 
Lower zone cavity 1 2 
Miliary 3 6 
Consolidation 10 20 
Total 50 100 
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Radiological findings No % 
Bilateral  20 40 
Unilateral  30 60 
Radiological findings No % 
Upper zone 19 38 
Mid zone 7 14 
Mid & lower zone 8 16 
Lower zone 10 20 
Others (military & diffuse) 6 12 
Radiological findings No % 
Typical findings 19 38 
Atypical findings 31 62 
 
                        
 
 
 
 
 
 
 
38% 
62% 
TYPICAL ATYPICAL
Chart 7:       RADIOLOGICAL   FINDINGS 
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B:RELATIONSHIP  BETWEEN  SPUTUM  SMEAR   
STATUS &  OTHER  VARIABLES  
AGE AND SPUTUM SMEAR STATUS: 
Table B1 : Age and sputum smear status 
 
Age group 
Sputum smear status 
Positive Negative 
No % No % 
13-20 years (0) - - - - 
21-30 years (6) 3 50 3 50 
31-40 years (26) 11 42.3 15 56.7 
41-50 years (15) 9 60 6 40 
51-60 years (2) 2 100 - - 
>60 years (1) - - 1 100 
Age 
Mean 
SD 
 
40.0 
8.2 
 
38.6 
8.0 
„p‟ 0.5199 
Not significant 
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         Mean age of presentation in sputum positive cases is 40 whereas it is 
38.6 in smear negative cases.  There was no stastistically significant 
correlation between age and sputum smear status (p=0.5199). 
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SEX   DISTRIBUTION  AND  SPUTUM  SMEAR  STATUS: 
          Sputum  positive and negative cases were equally distributed among 
males  and  females. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chart 9: SEX DISTRIBUTION AND SPUTUM  SMEAR STATUS 
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Table B2 : Sex distribution and sputum smear status 
 
Sex 
Sputum smear status 
Positive Negative 
No % No % 
Male (39) 19 48.7 20 51.3 
Female (11) 6 54.5 5 45.5 
„p‟        0.7354 (Not significant) 
 
SPUTUM   SMEAR  STATUS  AND  CD4  COUNT: 
Table B3 : Sputum smear status and CD4 count 
 
CD4 count 
Sputum smear status 
Positive Negative 
No % No % 
Upto 200 (32) 11 34.4 21 65.6 
>200 (18) 14 77.8 4 22.2 
CD4 count 
Mean 
SD 
 
231.9 
104.7 
 
113.8 
78.1 
„p‟         0.0001    (Significant) 
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      When  CD4 count was  less than 200,sputum negative cases were 
common while sputum positive cases dominated in CD4 count more than 
200 with a statistically significant difference (p=0.0001). 
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RADIOLOGICAL  FINDINGS  AND  SPUTUM  SMEAR  STATUS: 
        Sputum  positivity  was  common  among patients with unilateral 
radiologic  findings  and  sputum  negativity  was prevalent among  patients 
with bilateral  findings and the difference was stastically 
significant(p=0.0015). 
Table B4 : Radiological findings and sputum smear status 
 
Radiological findings 
Sputum smear status 
Positive Negative 
No % No % 
Bilateral (20) 4 20 16 80 
Unilateral (30) 21 70 9 30 
„p‟          0.0015  (Significant) 
 
 
Radiological findings 
Sputum smear status 
Positive Negative 
No % No % 
Typical (19) 15 78.9 4 21.1 
Atypical (31) 10 32.3 21 67.7 
„p‟           0.0036  (Significant) 
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    Typical findings include upper lobe infiltration,upper lobe cavity and 
upper lobe consolidation. Sputum positivity was common among patients 
with typical radiological findings whereas sputum negativity was seen 
among patients with atypical radiological findings. 
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C : RELATIONSHIP BETWEEN CD4 COUNT AND OTHER 
VARIABLES  
AGE AND CD4 COUNT: 
 Majority of cases were in the age group of 31 to 40 years with CD4 count 
less than 200. There is no correlation between CD4 count and age. 
Table C1  : Age and CD4 count 
 
Age group  
( in years) 
CD4 Count 
<200 >200 Mean SD 
No % No % 
13-20 (0) - - - - - - 
21-30 (6) 4 66.7 2 33.3 188.5 108.5 
31-40 (26) 19 73.1 7 26.9 145.6 102.6 
.941-50 (15) 9 60 6 40 184.8 106.7 
51-60 (2) - - 2 100 360.5 76.4 
1>60 (1) - - 1 100 234 - 
„p‟ 0.1604  
Not significant 
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SEX AND CD4 COUNT: 
     Among males the mean CD4 count was 107.1 whereas the mean CD4 
count  among females is 119.9. 
 
 
 
 
0
50
100
150
200
250
300
350
400
21 - 30 31 - 40 41 - 50 51 - 60 > 60
188.5 
145.6 
184.8 
360.5 
234 
M
e
a
n
 C
D
4
 c
o
u
n
t 
AGE GROUP 
MEAN CD4 COUNT
Chart 12:  AGE AND CD4 COUNT 
71 
 
Table C2 : Sex and CD4 count 
 
Sex 
CD4 Count 
<200 >200 Mean SD 
No % No % 
Male (39) 25 64.1 14 35.9 167.8 107.1 
Female (11) 7 63.6 3 36.4 190.6 119.9 
„p‟                             0.5582    (Not significant) 
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TIME  INTERVAL  AND  CD4  COUNT: 
             Majority of the newly diagnosed cases of pulmonary tuberculosis had 
a CD4 count less than 200. But there was no statistically significant 
difference between time interval and CD4 count. 
Table C3 : Time interval and CD4 count 
 
Time  
Interval 
CD4 Count 
<200 >200 Mean SD 
No % No % 
New (26) 19 73.1 7 26.9 154.4 109.5 
1 year (6) 5 83.3 1 16.7 112.3 121.6 
2 years (6) 3 50 3 50 226.2 80.3 
3 years (1) - - 1 100 240 - 
4 years (1) - - 1 100 304 - 
5 years (3) 1 33.3 2 66.7 241 80.9 
>5 years (7) 4 57.1 3 42.9 190.1 114.7 
„p‟ 0.2171  
Not significant 
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SPUTUM   DENSITY  AND  CD4  COUNT: 
             Sputum negative pulmonary tuberculosis was common when CD4 
count was less than 200.  
Table C4 : Sputum density and CD4 count 
 
Sputum density 
CD4 Count 
<200 >200 Mean SD 
No % No % 
Negative (25) 21 84 4 16 113.8 78.1 
Scanty (7) 4 57.1 3 42.9 184.6 99.1 
1+ (5) 2 40 3 60 237.6 72.5 
2+ (6) 2 33.3 4 66.7 234.7 108.1 
3+ (7) 3 42.9 4 57.1 272.7 127.3 
‘p’ 0.0006 
Significant 
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As the CD4 count increases,  sputum positivity with higher  density  
rises.  There was a  statistically significant difference between the two 
groups( p=0.0006). 
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RADIOLOGICAL  FINDINGS  AND  CD4  COUNT: 
          Though  bilateral findings were commonly   seen with CD4 
count<200, the difference was not statistically significant(p=0.4697). 
Table C5 : Radiological findings and CD4 count  
 
Radiological 
findings 
CD4 Count 
<200 >200 Mean SD 
No % No % 
Bilateral (20) 13 65 7 35 160.4 107.3 
Unilateral (30) 19 63.3 11 36.7 181.2 111.4 
„p‟                            0.4697  (Not significant) 
 
 
Radiological 
findings 
CD4 Count 
<200 >200 Mean SD 
No % No % 
Typical (19) 1 5.3 18 94.7 292.6 56.3 
Atypical (31) 31 100 - - 99.5 53.9 
„p‟                            <0.0001    (Significant) 
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All  patients who had a  CD4 count less than 200 had atypical chest X 
ray findings with a statistically significant difference(p<0.0001). 
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DISCUSSION 
              While many  HIV-related  opportunistic  infections manifest at  
lower CD4  counts, tuberculosis is one infection which  occurs  irrespective  
of CD4 counts, although its incidence  increases with  increasing  
immunosuppression. Several studies done in  HIV-TB coinfection   showed 
that they   have severe immunosuppression at presentation, possessing  CD4 
counts of less than 200. In our study , a larger proportion of cases were 
found to be in the CD4 count  range of less than 200(32/50,64%). This 
confirms the fact that tuberculosis is the most common opportunistic 
infection in HIV patiens with CD4 count less than 250. 
             In our study,26 cases(52%) had pulmonary tuberculosis at the initial 
diagnosis of HIV infection. This undoubtedly proves the necessity of 
intensive case finding measures to screen for pulmonary tuberculosis in all 
HIV patients . The reason for this higher incidence of tuberculosis at the time 
of initial presentation may be explained by larger number of patients having 
a  CD4 count of  less than 200.   
Among the 26 cases, CD4 count less than 200 was present in 
19(73.1%)  . In our study ,  significant number of TB cases( 6 cases_12%) 
were  diagnosed in the first year after HIV infection. This finding confirms 
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the fact that the  incidence of tuberculosis is higher in the first year of HIV 
seroconversion.  
         Our study also  showed a declining trend in the   occurrence  of  TB in 
the third, fourth and fifth year after diagnosing HIV infection. This may be 
substantiated by the fact the mean CD4 count in these cases was on a higher 
range,240,304 and 241 respectively. 
              In a country like India with resource limited settings, sputum smear 
microscopy and  chest  X  ray remains the cornerstone methods  for 
diagnosing  pulmonary tuberculosis. 
          Various studies done in the past have shown that sputum negativity is 
common in HIV_TB coinfection. In our study  , we found that sputum 
negative and sputum positive  cases  occurred with equal frequency  with 25 
among the 50 cases having sputum smear negative pulmonary 
tuberculosis(50%).  
          Studies by Pitchenick
(52)
 et al showed that HIV_TB coinfected 
individuals are less likely to have sputum smear positivity( 50/74,68%) 
compared to HIV seronegative individuals(172/215,80%). Also sputum 
culture positivity for M.tuberculosis was less in  the presence of HIV  
infection(61/74,82%) compared to non_HIV infected 
individuals(196/215,91%). 
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Smith et al
(53)
 observed that acid fast smears occur with equal 
frequency  among  HIV infected  and non_HIV infected patients. 
Klein et al
(54)
 showed a decreased sensitivity of sputum smears in 
pulmonary tuberculosis among HIV patients(45% versus 81%). 
Long et al
(55)
 found 66% sputum smear positivity among HIV infected 
individuals compared to 78% among non_HIV infected individuals. 
Studies by Praveen kumar
(56)
 et al showed a sputum smear  positivity 
of 21.4% among HIV_TB coinfected individuals. 
Rajasekaran et al
(57)
 reported 15.3% patients as smear positive. 
Thus there have been wider variations in the occurrence of sputum 
smear  positivity in HIV_TB coinfection. 
Hence we tried to analyse the relationship  between the sputum smear 
status and the severity  of immunosuppression expressed in terms of CD4 
count. Among the 25 sputum negative  cases,  CD4 count less than 200  was 
present in 21 cases whereas  CD4 count  more  than 200 was present only in 
4 cases. Among the 25 sputum positive cases,  CD4 count less than 200 was 
present in 11 cases whereas  CD4 count more than 200 was present in 14 
cases. Applying chi square test there was a statistically significant 
correlation between sputum smear status and CD4  count. Thus we 
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concluded that sputum smear positivity decreases as the CD4 count 
decreases. This endorses the fact by WHO that sputum negativity increases 
with increase in the degree of immunosuppression. 
The findings of our study were indifferent from those done by Sameer 
singhal et al
(58)
 who showed that acid fast smear positivity to negativity was 
1:1 when the CD4 count is between 0 to 200 whereas it was 3:1 in cases with 
CD4 count above 200. 
However ,our study had the limitation of missing few sputum positive 
cases as  sputum culture was not done in our study which has better 
sensitivity than sputum smear microscopy. 
         We also derived additional information supporting this fact by 
comparing the  sputum bacillary density with CD4 count which clearly 
showed a statistically significant correlation between sputum density and 
CD4 count.  
Among the sputum negative cases the average CD4 count was 113.8 
whereas in patients with scanty positivity,1+,2+,3+ the average CD4 count 
was 184.6, 237.6, 234.7, 272.7 respectively. As the CD4 count dropped, 
sputum density decreased. This finding corroborated with the findings of 
previous study done by Muqusi F et al
(59)
. 
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Hence a high degree  of clinical suspicion is needed to diagnose 
pulmonary tuberculosis among HIV infected individuals especially when  
CD4 count  is less than 200. 
            In our study we also tried to analyse the radiological findings among 
HIV_TB coinfected individuals. 
            Tuberculosis usually involves the upper lobes  unilaterally  
manifesting  as  infiltration,cavity,consolidation,fibrosis and volume loss. 
Mahesha Padyana et al
(5)
 showed in their study that among patients with 
HIV_TB  coinfection, bilateral lung involvement was common . 27.7% 
bilateral consolidation, 17%  miliary pattern occurred  in TB /HIV versus  
12% pulmonary bilateral consolidation, 4.7% miliary pattern in   of  HIV 
negative tuberculosis patients. 
             Studies by Pearlman et al showed infiltrates   among 67%,  cavity in 
20%, pulmonary nodule in 20%, interstitial disease in 17%,   pleural effusion 
in 10% and  lymphadenopathy in 7%.  3% of patients had a normal X ray. 
.        Observations made  by Maniar et al
(60)
  in patients with HIV  TB 
coinfection, showed unilateral involvement in 71.8% patients and bilateral 
involvement in 28.2% cases .There was involvement of  upper zone in  
3.7%, middle zone in 62.5% and  lower zone  in 33.8% of patients. 
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           In our study, we found that the most common manifestation of 
pulmonary tuberculosis among HIV infected individuals in chest X ray was 
infiltration(62%) followed by consolidation(20%) and cavity(12%).This 
clearly shows that the occurrence of cavity is uncommon with HIV_TB 
coinfection. Miliary pattern occurred in 3 cases(6%) in our study.           
We also observed that bilateral findings occurred in increasing 
incidence among HIV infected individuals( 40% ). While upper zone 
involvement was seen in 38% cases, midzone ,lowerzone and diffuse 
involvement dominated the scenario(62%). Thus atypical findings were 
common compared to typical findings(62% versus 32%). 
Observations of our study correlated with the findings of previous 
studies done by Praveen kumar et al
(56)
 which showed typical versus atypical 
findings(30.3%  versus 69.7%). 
         We also tried to analyse the correlation between radiological findings 
and sputum smear  status. We observed that atypical findings were common 
with sputum smear negative cases. Among the 25 smear negative cases,21 
had atypical findings and  the difference was statistically significant. This 
was explained by the fact  that all the cases with  atypical findings occurred 
among individuals with  CD4 count <200 among whom sputum negativity 
increased.  In contrary to the expectations, we also found that sputum 
negativity was common among cases with bilateral radiologic findings. 
83 
 
Therefore our study explains the fact that in early HIV  clinical profile 
of pulmonary tuberculosis mimics post primary tuberculosis whereas the 
presentation in advanced HIV mimics primary tuberculosis. 
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CONCLUSION 
1. HIV  TB  coinfection  is often   associated with  reduced  CD4  counts. 
2. Pulmonary tuberculosis  in HIV infected individuals  has lower 
sputum AFB  density. As the  CD4 cell count count decreases,sputum 
AFB density decreases. 
3.  The  most  common  radiological findings   in HIV TB coinfection are  
infiltration, consolidation and  cavity. Atypical findings such as 
diffuse involvement, mid zone and lower zone involvement and 
bilateral findings are common in HIV TB coinfection. 
4. Our study  endorsed WHO‟s  fact  that sputum smear  negativity 
increases as the CD4 count falls below 200. Though sputum smear 
microscopy remains a gold standard method for diagnosing pulmonary 
tuberculosis in immunocompromised host with CD4 count more than 
200,there is an urgent need for better diagnostic tools in patients with 
CD4 count below 200. 
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PROFORMA 
Name: 
Age: 
Sex: Male/Female 
Address: 
Occupation: 
History of present illness: 
1. cough 
2. fever 
3. hemoptysis 
4. weight loss 
5. loss of appetite 
Past history: 
Diabetes mellitus / Hypertension / chronic kidney disease / CAHD /                               
drug intake/HIV 
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General Examination: 
Systemic Examination: 
CVS: 
RS: 
PER ABDOMEN: 
CNS: 
Investigations: 
CBC 
Blood sugar 
           Urea 
Serum creatinine 
LFT 
Sputum AFB  _A 
                      _B 
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ICTC 
CD4 count 
Chest X ray 
CT chest 
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MASTER CHART 
SL. 
NO. 
NAME 
A
G
E
 
S
E
X
 
D
U
R
A
T
IO
N
 
SPUTUM 
STATUS 
SPUTUM 
DENSITY 
CD4 
COUNT 
RADIOLOGICA
L FINDINGS 
1 Sheikh jamal 32 M New Positive 1+ 195 Left lower zone 
consolidation 
2 Mariappan 36 M New Negative  216 Bilateral upper 
zone infiltrates 
3 Murugan 42 M 1 Negative  23 Right midzone 
consolidation 
4 Meena 30 F New Negative  172 Bilateral lower 
zone infiltrates 
5 Mariappan 36 M New Positive 2+ 105 Right lowerzone 
consolidation 
6 Murugan 40 M New Positive Scanty/6 50 Miliary  
7 Velthai 37 F 1 Negative  40 Bilateral diffuse 
infiltrates 
8 Manikandan 34 M New Positive 1+ 295 left upper zone 
infiltrates 
9 Marimuthu 41 M New Positive scanty/9 271 Bilateral upper 
zone infiltrates 
10 Shanmuganath
an 
42 M New Negative  39 Bilateral mid and 
lower zone 
infiltrates 
11 Subramani 38 M New Negative  99 Bilateral lower 
zone infiltrates 
12 Jeyendrasanka
r 
36 M New Negative  116 Left mid zone 
consolidation 
13 Anthony 33 M 8 Positive 3+ 69 Right lowerzone 
cavity 
14 Murugesan 40 M New Positive Scanty/5 98 Left lower zone 
infiltrates 
15 Kathar mydeen 41 M 6 
months 
Positive 1+ 133 Right midzone 
consolidation 
16 Kamaraj 49 M New Negative  166 Bilateral mid and 
lower zone 
infiltrates 
17 Muthu 36 M 9 Positive 3+ 193 Right upper zone 
infiltrates 
18 Muthu 27 M 4 Positive 1+ 304 Bilateral upper 
zone infiltrates 
19 Madasamy 45 M New Positive Scanty/5 313 Right upper zone 
cavity 
20 Murugalakshm
i 
31 F New Negative  66 Bilateral diffuse 
infiltrates 
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21 Thangamalai 35 M New Negative  49 Bilateral mid and 
lower zone 
infiltrates 
22 Sheikh davood 45 M New Negative  195 Left lower lobe 
consolidation 
23 Ranganathan 40 M 2 Negative  297 Bilateral upper 
zone infiltrates 
24 Manikandan 65 M New Negative  234 Bilateral upper 
zone infiltrates 
25 Rathakrishnan 39 M 3 Negative  240 Right upper zone 
infiltrates 
26 Muruganantha
n 
33 M 6 
months 
Negative  121 Bilateral lower 
zone infiltrates 
27 Ramalingam 47 M 2 Positive 2+ 248 Right upper zone 
cavity 
28 Mumtaj 48 F New Positive 2+ 96 Right lower lobe 
consolidation 
29 Paramasivan 48 M 5 Positive Scanty/7 261 Left upper zone 
infiltrates 
30 Manikandan 37 M 6 
months 
Positive 2+ 339 Right upper lobe 
consolidation 
31 Subramanian 33 M New Negative  33 Bilateral diffuse 
infiltrates 
32 Ulagammal 55 F New Positive 3+ 411 Bilateral upper 
zone infiltrates 
33 Maniraj 31 M New Negative  103 Bilateral mid and 
lower zone 
infiltrates 
34 Muthu 48 M 2 Y Positive 3+ 179 Left mid zone 
cavity 
35 Raju 35 M 2 Y Positive Scanty/3 173 Right midzone 
consolidation 
36 Kumar 32 M 2 Y Positive 3+ 334 Right upper zone 
cavity 
37 Murugan 40 M New Negative  72 Bilateral mid and 
lower zone 
infiltrates 
38 Petchiammal 30 F 2 Y Positive Scanty/12 126 Right mid and 
lower zone 
infiltrates 
39 Punniabharathi 30 M 6 Y Negative  47 Left mid and lower 
zone infiltrates 
40 Ponnarasi 39 F 7 Y Positive 2+ 310 Left upper zone 
infiltrates 
41 Vasantha 28 F 5 Y Negative  152 Left mid zone 
infiltrates 
42 Gomathy 37 M New Negative  33 Miliary  
43 Ramalakshmi 45 F 7 Y Positive 1+ 261 Bilateral upper 
zone cavity 
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44 Sankar 37 M 6 Y Negative  121 Bilateral mid and 
lower zone 
infiltrates 
45 Kanagaraj 60 M 5 Y Positive 2+ 310 Right upper zone 
infiltrates 
46 Jeyakumar 35 M 1 Y Negative  18 Left mid zone 
consolidation 
47 Maniyammal 29 F 7 Y Positive 3+ 330 Right upper zone 
infiltrates 
48 Petchiammal 50 F New Negative  133 Bilateral lower 
zone infiltrates 
49 Manikam 45 M New Negative  61 Miliary  
50 Raveendran 43 M New Positive 3+ 393 Left upper zone 
infiltrates 
 
 
 
 
 
 
 
 
